Many of the genes annotated with these PR-binding sites are critical regulators of cell migration, metabolic processes, and biosynthetic processes (Yin P and Bulun SE, unpublished data), and affect pathways including ErbB and insulin signaling, as well as pathways in cancer. The gene discussed is INS; the disease is cancer.